UnitedHealth Group closed at $378.81, up 2.12% and ahead of the S&P 500's 0.6% gain, with the Dow adding 0.83% and the Nasdaq up 0.64%. The largest U.S. health insurer is scheduled to report earnings on October 13, 2026, with analysts projecting EPS of $4.12, a 41.1% increase from the year-ago quarter, and revenue of $111.38 billion, down 1.57%. Full-year Zacks Consensus Estimates call for earnings of $19.85 per share and revenue of $446.78 billion, representing year-over-year changes of +21.41% and -0.18%. Over the past 30 days the Zacks Consensus EPS estimate has risen 0.15%, and UnitedHealth Group holds a Zacks Rank of #2 (Buy). The stock trades at a Forward P/E of 18.69 versus an industry average of 20.83, with a PEG ratio of 1.39.
UnitedHealth Group IncorporatedAnalysts project 41.1% EPS growth for the upcoming earnings report and the Zacks Consensus EPS estimate has risen over the past 30 days, with a #2 (Buy) rank.
